OBJECTIVE: Abdominoperineal resection (APR) is a disfiguring procedure, frequently associated with significant urogenital dysfunction. The aim of this prospective study was to repeatedly assess quality of life (QoL) 1, 6, and 12 months after APR. METHODS: Twenty patients who underwent APR between June 2002 and September 2005 were considered for analysis. QoL was assessed using two self-rating validated questionnaires developed by the European Organization for Research and Treatment of Cancer (EORTC). RESULTS: All patients were free of recurrence at time of last interview. At 1-year follow-up patients reported significant improvement in global QoL [scores: 53 +/- 23 (1 month) vs. 70 +/- 15 (1 year), P = 0.01], and physical function (74 +/- 16 vs. 91 +/- 12, P = 0.001). Patients also reported significant improvement in symptoms such as fatigue (39 +/- 30 vs. 15 +/- 19, P = 0.01); and pain (33 +/- 31 vs. 10 +/- 14, P = 0.01). By contrast, there was no improvement at 1 year for the following items: body image (75 +/- 33 vs. 75 +/- 30, P = 0.99), sexual dysfunction (10 +/- 21 vs. 21 +/- 27, P = 0.40); and stoma-related problems (19 +/- 14 vs. 11 +/- 28, P = 0.34). CONCLUSION: One year after APR, patients demonstrated significant improvement in global QoL and tumor-related symptoms, while body image remained significantly altered. Similarly, treatment-related side effects did not improve over the time period considered. (c) 2007 Wiley-Liss, Inc.
OBJECTIVE: Abdominoperineal resection (APR) is a disfiguring procedure, frequently associated with significant urogenital dysfunction. The aim of this prospective study was to repeatedly assess quality of life (QoL) 1, 6, and 12 months after APR. METHODS: Twenty patients who underwent APR between June 2002 and September 2005 were considered for analysis. QoL was assessed using two self-rating validated questionnaires developed by the European Organization for Research and Treatment of Cancer (EORTC). RESULTS: All patients were free of recurrence at time of last interview. At 1-year follow-up patients reported significant improvement in global QoL [scores: 53 +/- 23 (1 month) vs. 70 +/- 15 (1 year), P = 0.01], and physical function (74 +/- 16 vs. 91 +/- 12, P = 0.001). Patients also reported significant improvement in symptoms such as fatigue (39 +/- 30 vs. 15 +/- 19, P = 0.01); and pain (33 +/- 31 vs. 10 +/- 14, P = 0.01). By contrast, there was no improvement at 1 year for the following items: body image (75 +/- 33 vs. 75 +/- 30, P = 0.99), sexual dysfunction (10 +/- 21 vs. 21 +/- 27, P = 0.40); and stoma-related problems (19 +/- 14 vs. 11 +/- 28, P = 0.34). CONCLUSION: One year after APR, patients demonstrated significant improvement in global QoL and tumor-related symptoms, while body image remained significantly altered. Similarly, treatment-related side effects did not improve over the time period considered. (c) 2007 Wiley-Liss, Inc.
Authors: P G Vaughan-Shaw; T Cheung; J S Knight; P H Nichols; S A Pilkington; A H Mirnezami Journal: Tech Coloproctol Date: 2012-07-10 Impact factor: 3.781
Authors: Susanne Merkel; Daniela Klossek; Jonas Göhl; Thomas Papadopoulos; Werner Hohenberger; Paul Hermanek Journal: Int J Colorectal Dis Date: 2009-06-02 Impact factor: 2.571
Authors: Marcia Grant; Carmit K McMullen; Andrea Altschuler; Mark C Hornbrook; Lisa J Herrinton; Christopher S Wendel; Carol M Baldwin; Robert S Krouse Journal: Clin J Oncol Nurs Date: 2012-10 Impact factor: 1.027
Authors: Jennifer Barsky Reese; Laura S Porter; Katelyn R Regan; Francis J Keefe; Nilofer S Azad; Luis A Diaz; Joseph M Herman; Jennifer A Haythornthwaite Journal: Psychooncology Date: 2014-02-26 Impact factor: 3.894
Authors: Dhruvin H. Hirpara; Arash Azin; Virginia Mulcahy; Emily Le Souder; Catherine O’Brien; Sami A. Chadi; Fayez A. Quereshy Journal: Can J Surg Date: 2019-08-01 Impact factor: 2.089
Authors: J Andersson; E Angenete; M Gellerstedt; U Angerås; P Jess; J Rosenberg; A Fürst; J Bonjer; E Haglind Journal: Br J Surg Date: 2013-06 Impact factor: 6.939